Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

A 12-year-old girl with very high testosterone and insulin resistance improved with birth control pills, suggesting PCOS can cause high testosterone without tumors.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Testosterone reduces heart damage and inflammation after injury.

Men and women react differently to opioids, with hormones potentially influencing these differences.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Two gene areas linked to male pattern baldness found, more research needed.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

AR polyglycine repeat doesn't cause baldness.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.